Menu
Currency
GWAS Study

Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.

Jiang DK, Sun J, Cao G et al.

23242368 PubMed ID
GWAS Study Type
11799 Participants
36 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

JD
Jiang DK
SJ
Sun J
CG
Cao G
LY
Liu Y
LD
Lin D
GY
Gao YZ
RW
Ren WH
LX
Long XD
ZH
Zhang H
MX
Ma XP
WZ
Wang Z
JW
Jiang W
CT
Chen TY
GY
Gao Y
SL
Sun LD
LJ
Long JR
HH
Huang HX
WD
Wang D
YH
Yu H
ZP
Zhang P
TL
Tang LS
PB
Peng B
CH
Cai H
LT
Liu TT
ZP
Zhou P
LF
Liu F
LX
Lin X
TS
Tao S
WB
Wan B
SH
Sai-Yin HX
QL
Qin LX
YJ
Yin J
LL
Liu L
WC
Wu C
PY
Pei Y
ZY
Zhou YF
ZY
Zhai Y
LP
Lu PX
TA
Tan A
ZX
Zuo XB
FJ
Fan J
CJ
Chang J
GX
Gu X
WN
Wang NJ
LY
Li Y
LY
Liu YK
ZK
Zhai K
ZH
Zhang H
HZ
Hu Z
LJ
Liu J
YQ
Yi Q
XY
Xiang Y
SR
Shi R
DQ
Ding Q
ZW
Zheng W
SX
Shu XO
MZ
Mo Z
SY
Shugart YY
ZX
Zhang XJ
ZG
Zhou G
SH
Shen H
ZS
Zheng SL
XJ
Xu J
YL
Yu L
Chapter II

Abstract

Summary of the research findings

To identify genetic susceptibility loci for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) in the Chinese population, we carried out a genome-wide association study (GWAS) in 2,514 chronic HBV carriers (1,161 HCC cases and 1,353 controls) followed by a 2-stage validation among 6 independent populations of chronic HBV carriers (4,319 cases and 4,966 controls). The joint analyses showed that HCC risk was significantly associated with two independent loci: rs7574865 at STAT4, P(meta) = 2.48 × 10(-10), odds ratio (OR) = 1.21; and rs9275319 at HLA-DQ, P(meta) = 2.72 × 10(-17), OR = 1.49. The risk allele G at rs7574865 was significantly associated with lower mRNA levels of STAT4 in both the HCC tissues and nontumor tissues of 155 individuals with HBV-related HCC (P(trend) = 0.0008 and 0.0002, respectively). We also found significantly lower mRNA expression of STAT4 in HCC tumor tissues compared with paired adjacent nontumor tissues (P = 2.33 × 10(-14)).

1,161 Chinese ancestry cases, 1,353 Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

11799
Total Participants
GWAS
Study Type
Yes
Replicated
4,319 Chinese ancestry cases, 4,966 Chinese ancestry controls
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.